DSpace@İnönü

Cytoprotective effects of molsidomine against methotrexate-induced

Basit öğe kaydını göster

dc.contributor.author Samdanci, ET
dc.contributor.author Huz, M
dc.contributor.author Ozhan, O
dc.contributor.author Tanbek, K
dc.contributor.author Pamukcu, E
dc.contributor.author Akatli, AN
dc.contributor.author Parlakpinar, H
dc.date.accessioned 2022-08-08T08:12:05Z
dc.date.available 2022-08-08T08:12:05Z
dc.date.issued 2019
dc.identifier.uri http://hdl.handle.net/11616/60090
dc.description.abstract Introduction and aim: Methotrexate (Mtx) is an antineoplastic and immunosuppressive drug that may cause hepatotoxicity, whereas molsidomine (Mol) is a vasodilating and antioxidant agent. This study aimed to investigate the potential protective effects of Mol in Mtx-induced liver toxicity in rats.
dc.description.abstract Materials and methods: Forty Wistar albino rats were equally divided into five groups: control, Mol, Mtx, Mol Mtx, and Mtx Mol. Following treatment, the animals were sacrificed, and liver tissue samples were histopathologically evaluated using Roening grading and Bcl-2 antibody staining. Tissue oxidants, antioxidants, and serum transaminases were measured and statistically compared across all groups.
dc.description.abstract Results: No hepatic fibrosis or steatosis was observed in any of the groups. In the Mtx group, grade 2 liver injury and score 2 Bcl-2 antibody staining were observed; however, in the Mol-Mtx group, these were lower (grade 1, score 1). There were no statistically significant differences in serum transaminase levels among groups. Malondialdehyde levels were higher in all rats that received Mtx, but no differences in myeloperoxidase levels were observed among the groups. Levels of tissue antioxidants, including superoxide dismutase, glutathione (GSH) peroxidase (GSH-Px), and reduced GSH, were significantly higher in the Mol-treated and Mol pre-treated groups. Catalan (CAT) levels were elevated in all Mol-treated groups, but only in that group were CAT levels statistically significantly higher than in the control group.
dc.description.abstract Conclusion: Our results suggest that some oxidant levels could increase following Mtx administration in the liver, possibly contributing to liver damage, whereas Mol could mitigate the histopathological and biochemical effects of hepatotoxicity. However, molecular studies are required to understand the exact mechanisms of these alterations.
dc.description.abstract C1 [Samdanci, Emine Turkmen; Huz, Mustafa; Akatli, Ayse Nur] Inonu Univ, Sch Med, Dept Pathol, Malatya, Turkey.
dc.description.abstract [Ozhan, Onural; Parlakpinar, Hakan] Inonu Univ, Sch Med, Dept Pharmacol, Malatya, Turkey.
dc.description.abstract [Tanbek, Kevser] Inonu Univ, Sch Med, Dept Physiol, Malatya, Turkey.
dc.description.abstract [Pamukcu, Esra] Firat Univ, Fac Sci, Dept Stat, Elazig, Turkey.
dc.source DRUG DESIGN DEVELOPMENT AND THERAPY
dc.title Cytoprotective effects of molsidomine against methotrexate-induced
dc.title hepatotoxicity: an experimental rat study


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster